MeSH D010505 - familial mediterranean fever
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Novast Laboratories | Colchicine, Probenecid | Probenecid Colchicine | 2008-05-13 | |||
| Mylan | Colchicine | Colchicine | 2019-09-16 | |||
| Sandoz | Colchicine, Probenecid | Probenecid Colchicine | 1982-01-01 | |||
| Novartis | Canakinumab | Ilaris | 2009-06-17 | $1,038 M | Q2/20-Q2/23 | |
| Merck Sharp & Dohme | Colchicine, Probenecid | Colbenemid | 1982-01-01 | |||
| Takeda | Colchicine | Colcrys | 2028-10-06 | 2009-07-29 | ||
| Aurobindo Pharma | Colchicine | Colchicine | 2022-01-06 | |||
| Dr Reddys Laboratories | Colchicine | Colchicine | 2019-09-06 | |||
| Zydus Therapeutics | Colchicine | Colchicine | 2019-02-19 | |||
| Alkem Laboratories | Colchicine | Colchicine | 2019-02-08 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
20%1/5
Phase 3
67%2/3
Approved: 2Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use